載入...
Development of peptidomimetic inhibitors of the ERG gene fusion product in prostate cancer
Transcription factors play a key role in the development of diverse cancers, and therapeutically targeting them has remained a challenge. In prostate cancer, the gene encoding the transcription factor ERG is recurrently rearranged and plays a critical role in prostate oncogenesis. Here, we identifie...
Na minha lista:
| 發表在: | Cancer Cell |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2017
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5443258/ https://ncbi.nlm.nih.gov/pubmed/28344039 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ccell.2017.02.017 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|